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mother-in-law! Based on these data, the authors rightly question if
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Dr Charles Sternbergh, III (NewOrleans, La). Dr Tulip and
colleagues bring us important and timely data today, emblematic
of the insightful research we have come to expect from the vascular
group at University of Texas Southwestern. In this study, 40
patients underwent carotid artery stenting (CAS), 23 for asymp-
tomatic and 17 for symptomatic disease. Subclinical evidence of
cerebral emboli was studied with intraprocedural transcranial
Doppler and diffusion-weighted magnetic resonance imaging
(DW-MRI) scans obtained preoperatively and postoperatively.
If this study cohort and design sounds familiar to this audi-
ence, it should. At this meeting in January 2011, the identical
patient cohort was presented, with the same outcome parameters
of transcranial Doppler hits and new DW-MRI brain lesions. That
randomized, prospective trial compared open-cell vs closed-cell
stents, and no difference between groups was seen in subclinical
emboli.1
Today, the study instead provides the subcohort data on
asymptomatic vs symptomatic patients. A sobering 50% rate of
ischemic brain injury was seen on DW-MRI in both groups. If the
late John Porter were still with us today, his Yearbook of Vascular
Surgery might have bestowed the authors with the dreaded
“salami-slicer” award for parsing out pieces of data into multiple
publications instead of in a single communication.
But here’s the thing: I understand why the authors chose not
to include these patient cohorts in the original publication. The
impact of the data might have been lost, or at least diminished.
Although the long-term clinical significance of these DW-MRI
lesions is uncertain, a 50% rate of acute brain injury, even if
clinically asymptomatic, cannot be a good thing. I would not wish
my mother to be subjected to such odds—gee, not even mylter-protected CAS in asymptomatic patients should be per-
ormed. I have two questions for the authors:
First, based on the presented data, do the authors feel it is
thical to offer CAS with filter protection to a patient with asymp-
omatic disease?
Second, flow-reversal or flow cessation protection has shown
romise in decreasing subclinical cerebral emboli in symptomatic
atients undergoing CAS. Has your group shifted to such embolic
rotection techniques, even in asymptomatic patients?
Dr Hans H. Tulip. Thank you, Dr Sternberg, I appreciate
our questions. In answer to your first question, I do feel that CAS
s safe for patients with asymptomatic carotid artery stenosis based
n current data. Because we do not know the effects of these silent
erebral emboli, carotid endarterectomy should be considered in
atients who are fit for open surgery. From here, we need to focus
ur efforts on identifying the subset of asymptomatic patients that
re more likely to benefit from surgery. Once this group is identi-
ed, carotid stenting and endarterectomy will provide maximal
enefit at acceptable risk to these patients. In answer to your
econd question, we are beginning to enroll patients in an Ameri-
an Heart Association–funded trial to determine the role for prox-
mal balloon occlusion and flow reversal compared with filter
mbolic protection devices to determine whether this reduces the
ncidence of these subclinical cerebral embolization and neuro-
ogic events.
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